Author:
Wang Zhuo,Ma Lijuan,Wang Xuebin,Cai Heping,Huang Jin,Liu Jiyong,Hu Jinhong,Su Dingfeng
Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),Cancer Research,Pharmacology,Toxicology,Oncology
Reference35 articles.
1. Myrianthefs P, Karatzas S, Baltopoulos G (2005) Complications, thrombophlebitis rates, and intravenous catheter replacement strategies. Infection 33:96–97
2. Tagalakis V, Kahn SR, Libman M et al (2002) The epidemiology of peripheral vein infusion thrombophlebitis: a critical review. Am J Med 113:146–151
3. Myrianthefs P, Sifaki M, Samara I et al (2005) The epidemiology of peripheral vein complications: evaluation of the efficiency of differing methods for the maintenance of catheter patency and thrombophlebitis prevention. J Eval Clin Pract 11:85–89
4. Lanbeck P, Odenholt I, Paulsen O (2003) Dicloxacillin: a higher risk than cloxacillin for infusion phlebitis. Scand J Infect Dis 35:397–400
5. Suga Y, Kumazaki M, Nishigami J et al (2009) Improvement of epirubicin-induced phlebitis to switch from liquid preparation to lyophilized formulation. Gan To Kagaku Ryoho 36:93–96
Cited by
10 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献